View in EDS HTML Full Text PDF Full Text

Incidence of Suspected Serious Adverse Drug Reactions in Corona Virus Disease-19 Patients Detected by a Pharmacovigilance Program by Laboratory Signals in a Tertiary Hospital in Spain: Cautionary Data.

Saved in:
Bibliographic Details
Title: Incidence of Suspected Serious Adverse Drug Reactions in Corona Virus Disease-19 Patients Detected by a Pharmacovigilance Program by Laboratory Signals in a Tertiary Hospital in Spain: Cautionary Data.
Authors: Ramírez E; Department of Clinical Pharmacology, La Paz University Hospital-IdiPAZ, School of Medicine, Autonomous University of Madrid, Madrid, Spain., Urroz M; Department of Clinical Pharmacology, La Paz University Hospital-IdiPAZ, School of Medicine, Autonomous University of Madrid, Madrid, Spain., Rodríguez A; Department of Clinical Pharmacology, La Paz University Hospital-IdiPAZ, School of Medicine, Autonomous University of Madrid, Madrid, Spain., González-Muñoz M; Department of Immunology, La Paz University Hospital-IdiPAZ, Madrid, Spain., Martín-Vega A; CSUR Coordination, La Paz University Hospital-IdiPAZ, Madrid, Spain., Villán Y; Safety and Quality Unit, La Paz University Hospital-IdiPAZ, Madrid, Spain., Seco E; Department of Clinical Pharmacology, La Paz University Hospital-IdiPAZ, School of Medicine, Autonomous University of Madrid, Madrid, Spain., Monserrat J; Department of Clinical Pharmacology, La Paz University Hospital-IdiPAZ, School of Medicine, Autonomous University of Madrid, Madrid, Spain., Frías J; Department of Clinical Pharmacology, La Paz University Hospital-IdiPAZ, School of Medicine, Autonomous University of Madrid, Madrid, Spain., Carcas AJ; Department of Clinical Pharmacology, La Paz University Hospital-IdiPAZ, School of Medicine, Autonomous University of Madrid, Madrid, Spain., Borobia AM; Department of Clinical Pharmacology, La Paz University Hospital-IdiPAZ, School of Medicine, Autonomous University of Madrid, Madrid, Spain.
Source: Frontiers in pharmacology [Front Pharmacol] 2020 Dec 03; Vol. 11, pp. 602841. Date of Electronic Publication: 2020 Dec 03 (Print Publication: 2020).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33343374
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Incidence of Suspected Serious Adverse Drug Reactions in Corona Virus Disease-19 Patients Detected by a Pharmacovigilance Program by Laboratory Signals in a Tertiary Hospital in Spain: Cautionary Data.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ramírez+E%22">Ramírez E</searchLink>; Department of Clinical Pharmacology, La Paz University Hospital-IdiPAZ, School of Medicine, Autonomous University of Madrid, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Urroz+M%22">Urroz M</searchLink>; Department of Clinical Pharmacology, La Paz University Hospital-IdiPAZ, School of Medicine, Autonomous University of Madrid, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Rodríguez+A%22">Rodríguez A</searchLink>; Department of Clinical Pharmacology, La Paz University Hospital-IdiPAZ, School of Medicine, Autonomous University of Madrid, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22González-Muñoz+M%22">González-Muñoz M</searchLink>; Department of Immunology, La Paz University Hospital-IdiPAZ, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Martín-Vega+A%22">Martín-Vega A</searchLink>; CSUR Coordination, La Paz University Hospital-IdiPAZ, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Villán+Y%22">Villán Y</searchLink>; Safety and Quality Unit, La Paz University Hospital-IdiPAZ, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Seco+E%22">Seco E</searchLink>; Department of Clinical Pharmacology, La Paz University Hospital-IdiPAZ, School of Medicine, Autonomous University of Madrid, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Monserrat+J%22">Monserrat J</searchLink>; Department of Clinical Pharmacology, La Paz University Hospital-IdiPAZ, School of Medicine, Autonomous University of Madrid, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Frías+J%22">Frías J</searchLink>; Department of Clinical Pharmacology, La Paz University Hospital-IdiPAZ, School of Medicine, Autonomous University of Madrid, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Carcas+AJ%22">Carcas AJ</searchLink>; Department of Clinical Pharmacology, La Paz University Hospital-IdiPAZ, School of Medicine, Autonomous University of Madrid, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Borobia+AM%22">Borobia AM</searchLink>; Department of Clinical Pharmacology, La Paz University Hospital-IdiPAZ, School of Medicine, Autonomous University of Madrid, Madrid, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2020 Dec 03; Vol. 11, pp. 602841. <i>Date of Electronic Publication: </i>2020 Dec 03 (<i>Print Publication: </i>2020).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33343374
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fphar.2020.602841
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 602841
    Titles:
      – TitleFull: Incidence of Suspected Serious Adverse Drug Reactions in Corona Virus Disease-19 Patients Detected by a Pharmacovigilance Program by Laboratory Signals in a Tertiary Hospital in Spain: Cautionary Data.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ramírez E
      – PersonEntity:
          Name:
            NameFull: Urroz M
      – PersonEntity:
          Name:
            NameFull: Rodríguez A
      – PersonEntity:
          Name:
            NameFull: González-Muñoz M
      – PersonEntity:
          Name:
            NameFull: Martín-Vega A
      – PersonEntity:
          Name:
            NameFull: Villán Y
      – PersonEntity:
          Name:
            NameFull: Seco E
      – PersonEntity:
          Name:
            NameFull: Monserrat J
      – PersonEntity:
          Name:
            NameFull: Frías J
      – PersonEntity:
          Name:
            NameFull: Carcas AJ
      – PersonEntity:
          Name:
            NameFull: Borobia AM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 12
              Text: 2020 Dec 03
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-print
              Value: 1663-9812
          Numbering:
            – Type: volume
              Value: 11
          Titles:
            – TitleFull: Frontiers in pharmacology
              Type: main
ResultId 1